Representative engagement

What decides lab adoption is not one thing. And it changes by region

A diagnostics business wanted to know what actually moves a laboratory to adopt. Not what it says in a tender document, but what the people signing it weigh up. So we asked eighty of them.

The challenge

Adoption is decided by people, not by the specification

A diagnostics business needed to understand what moves a clinical laboratory from evaluating a product to running it.

That decision does not sit with one person or in one document. A pathology lab decides on things that never appear on a product sheet, weighed by the people who will live with the result.

The client also needed to know whether the weighting held across regions, because pricing and support are set regionally even when the product is global.

The Nextyn approach

Eighty decision makers, one survey with experts behind it

The work was an expert backed survey with eighty pathology and laboratory decision makers across the USA, the UK and EMEA.

Expert backed matters here. A survey written without category expertise asks about features. One written with it asks about the things that decide a purchase, which in a clinical laboratory are rarely the features.

Eighty is enough to hold up regionally rather than only in aggregate. That is what lets the answer be read market by market instead of as one global average.

Healthcare market research at this level is a segmentation exercise as much as a survey. The point is not the average respondent but which kind of account behaves which way.

The outcome

Service, training, and whether it fits the systems

The survey isolated the factors that mattered most: service, training and data integration.

Data integration is the one that tends to be underweighted before a purchase and overweighted after it. A laboratory information system that will not accept the output cleanly turns a good instrument into a manual process.

The weighting moved by region, which is the finding that changed how the client planned rather than how it marketed.

That fed directly into sharper pricing, support and account priorities. The diagnostics market rewards the supplier that has understood the operational reality, and this told the client where its own gaps were.

Related reading

More on what actually decides a laboratory purchase

Recent analysis from the Nextyn Research desk.

Start here

Need to know what really decides it? We ask the people who sign

Tell us the category and the markets, and what the pricing decision rests on. A named research lead replies directly.

Request a research proposal

What do you need to know?

A named research lead replies, not a queue.

We use these details to route your brief. No newsletter, no list.

Your privacy choices

We measure how this site is used and which campaigns bring people here. You can opt out at any time, which also stops any sale or sharing of your personal information for advertising.